Shaanxi Kanghui Pharmaceutical Co., Ltd. (SHA:603139)

Market Cap	2.36B +74.1%
Revenue (ttm)	513.23M -15.2%
Net Income	-183.84M
EPS	-1.86
Shares Out	99.88M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	3,298,612
Average Volume	3,047,492
Open	23.15
Previous Close	22.93
Day's Range	22.81 - 23.85
52-Week Range	14.00 - 30.20
Beta	0.18
RSI	57.59
Earnings Date	Apr 24, 2026

About SHA:603139

Shaanxi Kanghui Pharmaceutical Co., Ltd. engages in the research and development, production, and sale of pharmaceutical products in China. It offers gynecological, orthopedic, dermatology, diabetes, respiratory system, urinary system, cardiovascular, tranquilizer, gastrointestinal, hepatobiliary, and other drugs in the form of tablets, capsules, granules, mixtures, teas, plasters, ointments, liniments, lotions, and tinctures. The company was founded in 1999 and is based in Xianyang, China.

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1999
• Employees: 906
• Stock Exchange: Shanghai Stock Exchange
• Ticker Symbol: 603139

Financial Performance

In 2024, SHA:603139's revenue was 561.63 million, a decrease of -16.54% compared to the previous year's 672.96 million. Losses were -89.63 million, 242.6% more than in 2023.